Value-Based Obesity Care in the GLP-1 Era: A company presentation and Q&A with Ilant Health founder and CEO Elina Onitskansky

​Every employer and health plan is caught in the same bind on obesity: expand GLP-1 access and watch pharmacy spend balloon, or restrict access and risk worse outcomes and higher downstream cost. Ilant Health's bet is that neither is sustainable. The company works with employers and payers across all 50 states, matching members to the right treatment in a clinician-led, value-based model, and recently raised a $15M Series A led by Cornucopian Capital.

Founder & CEO Elina Onitskansky will give HTN share a presentation on Ilant's model, its latest raise, and how it's approaching the obesity-cost tension, followed by analyst Q&A from HTN's Kevin O'Leary.

Live event open to everyone, replay and transcript exclusively available for HTN Pros.